In a move intended to lower out-of-pocket prescription drug costs for beneficiaries, the Centers for Medicare and Medicaid Services issued a proposed rule Thursday updating the Medicare Advantage and Medicare Part D programs, tasking the former with being more transparent in how it spends money on supplemental benefits, and the latter with applying price concessions from drugmakers to the point of sale.
CMS proposed rule seeks to lower Medicare Part D prescription drug costs
